Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Sector: Medical
EPIX (OTCBB: EPIX)
3m
6m
1y
2y
Ranking History
This Week
Last Week
Two Weeks Back
Three Weeks Back
Please login to view our current ranking data
Click here to login
No Information
No Information
No Information
Disclaimer
Headlines
Blog Articles
Press Releases
SEC
Joseph F. Finn, Jr., Assignee for the Benefit of Creditors of EPIX Pharmaceuticals, Inc., Releases Statement Regarding Liquidation Process
Oct 22, 2009 03:05 PM |
EPIX
EPIX Pharmaceuticals Announces FDA Approval of a Physician-Sponsored IND for Fourth 6-month Open Label Extension of PRX-03140 for Alzheimer's Disease Patient
Oct 16, 2009 12:48 PM |
EPIX
Epix Pharmaceuticals, Inc. Announces a Successful Auction Sale of Five Drug Program Intellectual Properties on September 30, 2009
Oct 01, 2009 10:35 AM |
EPIX
Elkan Gamzu, Ph.D. Joins Hygeia Therapeutics' Board of Directors as Chair
Sep 14, 2009 07:15 AM |
EPIX
EPIX Pharmaceuticals, Inc. Announces the P2Y2 Gastrointestinal Early Development Candidate Program Will Be Part of the Intellectual Property Offered For Sale at the September 30, 2009 Auction
Sep 01, 2009 11:13 AM |
EPIX
FDA Clinical Trial Calendar Updates: SOMX, EPIX, HLUKY, ARKTF
Apr 07, 2009 11:58 PM |
EPIX
,
SOMX
A Quick Look at Lionsgate Films
Jan 18, 2009 11:59 PM |
EPIX
,
JPM
,
LGF
,
MVSN
,
VOD
FDA Calendar: Allergan's New Rx for Eyelashes
Dec 27, 2008 10:31 PM |
AGN
,
ALO
,
DDSS
,
EPIX
,
GENZ
,
SVNT
7 Hot Stocks You Should Know About
Dec 24, 2008 04:00 PM |
BXC
,
CPY
,
EPIX
,
IMAX
,
MBLX
,
OESX
TapImmune Provides Shareholder Update and Review and EPIX Pharmaceuticals to Participate in Panel Session at the Neurotech Industry Investing and Partnering Conference
May 02, 2008 01:44 PM |
DSCO
,
EPIX
,
NVAX
More..
More..
Lionsgate Reports Net Income of $36.3 Million and Adjusted EBITDA of $53.0 Million for First Quarter of Fiscal 2010
Aug 10, 2009 04:52 PM |
EPIX
,
LGF
Biotech Hot in July Driven By Positive Drug Data and Acquisitions
Aug 03, 2009 01:14 PM |
EPIX
,
FRX
,
HGSI
,
OREX
EPIX Pharmaceuticals Assigns All of Its Assets for the Benefit of Creditors
Jul 20, 2009 06:51 PM |
EPIX
EPIX Pharmaceuticals Announces Noteholders’ Right to Require the Company to Repurchase $3.2 Million Outstanding Balance of 3% Convertible Senior Notes Due 2024
Jun 03, 2009 04:12 PM |
EPIX
EPIX Pharmaceuticals Announces Receipt of NASDAQ Panel Decision to Delist Common Stock
May 13, 2009 05:21 PM |
AMGN
,
EPIX
EPIX Pharmaceuticals Announces First Quarter 2009 Financial Results
May 11, 2009 04:51 PM |
EPIX
EPIX Pharmaceuticals Announces Final Results of Exchange Offer for $100 Million Convertible Notes
May 05, 2009 08:59 AM |
EPIX
EPIX Pharmaceuticals Commences Exchange Offer for $100 Million Convertible Notes
Apr 07, 2009 06:32 AM |
EPIX
EPIX Pharmaceuticals Announces Sale of U.S., Canadian and Australian Rights for MS-325 (formerly marketed as Vasovist®, gadofosveset trisodium, by Bayer Schering Pharma) to Lantheus Medical Imaging, Inc.
Apr 07, 2009 06:31 AM |
EPIX
EPIX Pharmaceuticals Receives Audit Opinion Containing Going Concern Qualification
Mar 25, 2009 04:46 PM |
EPIX
More..
Form 3 PRESCOTT GROUP CAPITAL For: Jul 21 (10K)
Jul 31, 2009 03:46 PM
Form 4 Drapkin Kimberlee C For: Jun 30 (10K)
Jul 01, 2009 06:13 PM
Form 4 SMITH IAN F For: Jun 16 (10K)
Jun 18, 2009 07:29 PM
Form 4 EPIX Pharmaceuticals, For: Jun 16 Filed by: PHELPS GREGORY D (10K)
Jun 18, 2009 07:26 PM
Form 4 Leuchtenberger Mark For: Jun 16 (10K)
Jun 18, 2009 07:22 PM
Form 4 Gilman Michael For: Jun 16 (10K)
Jun 18, 2009 07:21 PM
Form 4 FRANK FRED For: Jun 16 (10K)
Jun 18, 2009 07:19 PM
Form 4 Drapkin Kimberlee C For: Mar 17 (10K)
Mar 19, 2009 02:33 PM
Form 4/A Schor Chen For: Feb 25 (10K)
Mar 03, 2009 05:53 PM
Form 4/A Drapkin Kimberlee C For: Feb 25 (10K)
Mar 03, 2009 05:50 PM
More..
Analyst Ratings
More Details
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
EPIX
Compare to S&P
YTD
-98.69 %
-98.92 %
4 Weeks
-46.00 %
-46.58 %
12 Weeks
45.16 %
36.85 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
20.83 %
EPS Growth in Last Year:
42.42 %
Sales Growth in Last Quarter:
-3.06 %
Sales Growth in Last Quarter:
51.54 %
More...
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
